Dimensional Fund Advisors
SQZ

Dimensional Fund Advisors’s SQZ Biotechnologies Company SQZ Stock Holding History

Dimensional Fund Advisors’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,402
Closed -$15 – 3521
2022
Q4 		$15 Buy
19,402
+418
+2% +$913 ﹤0.01% 3472
2022
Q3 		$43K Buy
18,984
+2,966
+19% +$8.9K ﹤0.01% 3419
2022
Q2 		$51K Buy
+16,018
New +$57.6K ﹤0.01% 3385

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's SQZ Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of SQZ Biotechnologies Company (SQZ) in Q1 2023, closing a stake of 19,402 shares — an estimated $15 sold.

Dimensional Fund Advisors first reported a position in SQZ in Q2 2022 and held it in 3 quarters. The position peaked at $51K in Q2 2022. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

  • Dimensional Fund Advisors reported no remaining SQZ Biotechnologies Company position as of Q1 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 19,402 SQZ Biotechnologies Company shares in Q1 2023, an estimated $15.
  • Dimensional Fund Advisors first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 3 quarters.
  • Dimensional Fund Advisors's SQZ Biotechnologies Company position peaked at $51K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.